Corcept Therapeutics | CORT - Frais De Vente Et D'Administration





Frais De Vente Et D'Administration Changement Date
Acadia Pharmaceuticals USD 148.57M 12.22M 2026-06
Alaunos Therapeutics USD 447K 138K 2026-03
ANI Pharmaceuticals USD 91.66M 18.01M 2026-06
Ardelyx USD 102.27M 26.35M 2026-03
Aurora Cannabis CAD 41.4M 781K 2026-03
BioMarin Pharmaceutical USD 395.55M 137.27M 2026-06
Bristol-Myers Squibb USD 1.83B 209M 2026-06
Canopy Growth CAD 31.17M 2.27M 2026-03
Corcept Therapeutics USD 156.9M 28.85M 2026-06
Eli Lilly USD 3.43B 496M 2026-06
J&J USD 6.25B 168M 2026-09
Knight Therapeutics CAD 35.45M 4.43M 2025-12
Lexicon Pharmaceuticals USD 3.98M 195K 2025-12
Merck USD 2.89B 219M 2026-06
Nektar Therapeutics USD 11.87M 1.7M 2026-03
Novartis USD 3.24B 101M 2026-06
Novartis USD 3.14B 296M 2026-03
Omeros USD 11.32M 2.48M 2024-09
Pacira USD 91.81M 7.93M 2026-06
Pfizer USD 3.41B 496M 2026-06
Supernus Pharmaceuticals USD 133.64M 15.41M 2026-06
TG Therapeutics USD 62.32M 10.82M 2026-06